New York Cannabis Products Recalled Over Unreliable Lab Testing Results
Key Takeaway
New York's OCM issued its first product recall of 2026 after inspections revealed Keystone State Testing issued inaccurate safety certificates. A records audit found 54 product lots falsely reported as passing Aspergillus mold tests, affecting products from nearly two dozen companies.
What This Means for Cannabis Businesses
Testing developments affect product safety, consumer trust, and regulatory compliance across the supply chain. Lab testing integrity is fundamental to the legal cannabis market - when labs fail or commit fraud, it undermines the entire system and puts consumers at risk. Operators should verify their testing lab's accreditation status and review COAs carefully for any irregularities.
New York Cannabis Market Overview
New York is one of the newest major recreational markets. Despite a slow rollout, the state has issued over 2,100 licenses and continues to expand. The state has approximately 2,161 active cannabis licenses and 13 licensed testing laboratories. There are 49 cannabis professionals serving New York businesses on our directory, including CPAs, attorneys, and compliance consultants.
Related Guides
Related News
New York Officials Report $2.5 Billion in Cannabis Sales Since Legalization
New York Governor Forces Two Top Cannabis Regulators to Resign
New York Legal Cannabis Sales Hit $1.5 Billion as Licensed Stores Double
Massachusetts Cannabis Lab Shuttered Over Fraud Allegations
This analysis is based on reporting by MJBizDaily. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.